Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jan 21 2026

Full Issue

CDC Official Downplays Potential Loss Of Measles Elimination Status In US

Ralph Abraham, principal deputy director of the CDC, claimed the continued spread of the virus is 'just the cost of doing business." As Stat notes, however, elimination status is lost if a country is unable to stop ongoing transmission of the virus and circulation continues for a year or longer.

Stat: Lost Measles Elimination Status 'A Cost Of Doing Business,' CDC Official Says

With measles transmission in the United States at levels that haven’t been seen in decades, the principal deputy director of the Centers for Disease Control and Prevention said Tuesday that he would not view the loss of the country’s measles elimination status as a significant event. (Branswell, 1/20)

The Hill: Healthcare Group Projects Anti-RFK Jr. Messages Onto HHS Building

Protect Our Care, a healthcare advocacy group, on Tuesday projected two critical messages onto the facade of the Health and Human Services (HHS) building in Washington, D.C., blaming HHS Secretary Robert F. Kennedy Jr. for policies they say are making Americans sicker. “RFK JR: MAKING AMERICA SICK AGAIN,” read one message, projected outside the building. Another message read: “MEASLES HQ.” (Fortinsky, 1/20)

In related news —

CIDRAP: South Carolina Measles Outbreak Expands By 200+, Reaches 646 Cases

In the past week, South Carolina officials have confirmed 212 new measles cases, raising the state total to 646 and threatening to overtake last year’s West Texas outbreak as the largest in decades in the United States. There are currently 538 people in quarantine and 33 in isolation, the South Carolina Department of Public Health said today. Six schools have recent public exposures that have resulted in new quarantines. (Soucheray, 1/20)

The Washington Post: Another Virginia Child Comes Down With Measles After Travel Abroad

A week after reporting a child with measles traveled through the region while contagious, Virginia public health officials on Tuesday reported the case of another young child with the illness and warned of possible public exposures. Both children were 4 or younger and contracted the disease after traveling internationally, but the cases are unrelated, according to the Virginia Department of Health. (Portnoy, 1/20)

KFF Health News: Listen To The Latest 'KFF Health News Minute' 

Jackie Fortiér reads the week’s news: Parents are confused by an overhaul of U.S. childhood immunization guidelines, and while people 65 and older make up the fastest-growing homeless population in the country, traditional homeless shelters often can’t accommodate them. (Cook, 1/20)

In other vaccine news —

Pharmaceutical Technology: Pfizer And Novavax Ink $530M Vaccine Delivery Licensing Deal 

Pfizer has signed a deal worth up to $530M with US-based vaccine technology company Novavax. This agreement will see Pfizer hand over $30M upfront for the non-exclusive rights to Novavax’s proprietary Matrix-M vaccine adjuvant, which is designed to boost and prolong the immune response when added to an injectable formulation. (Allen, 1/21)

MedPage Today: Ixchiq Vaccine Pulled From U.S. Market Amid Safety Concerns

Vaccine maker Valneva will pull its chikungunya vaccine (Ixchiq) from the U.S. market after the FDA announced it would take further action to investigate the live-attenuated shot. The FDA recently put the investigational new drug application for a post-marketing study on clinical hold while the agency investigated a newly reported serious adverse event in a vaccine recipient abroad, according to Valneva. The company said the event "involved a younger adult who received three concomitant vaccines, including Ixchiq." (Rudd, 1/20)

CIDRAP: Shingles Vaccine May Slow Biological Aging In Older Adults

In addition to helping protect against a painful viral illness, the shingles (herpes zoster) vaccine may help slow biological aging in older adults, according to a new observational study by researchers at the University of Southern California (USC) Leonard Davis School of Gerontology. Biological age differs from chronological age in that it reflects how well the body’s tissues and organ systems are working. (Bergeson, 1/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF